跳至主要内容
临床试验/NCT06029699
NCT06029699尚未招募不适用

High Flow Nasal Cannula Versus Non Invasive Positive Pressure Ventilation in Reducing Reintubation in Mechanically Ventilated Patient

Assiut University0 个研究点目标入组 50 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
the need for re-intubation and weaning success which will be measured by arterial blood gas ( ABG )

研究概览

简要总结

This is study aim to compare between high flow nasal canula (HFNC) and non invasive positive pressure ventilation (NIPPV) in reducing the rate of reintubation in mechanically ventilated patient with successful weaning

详细描述

  • High-flow nasal cannula (HFNC) oxygen therapy comprises an air/oxygen blender, an active humidifier, a single heated circuit, and a nasal cannula. It delivers adequately heated and humidified medical gas at up to 60 L/min of flow and is considered to have a number of physiological effects: reduction of anatomical dead space, positive end expiratory pressure ( PEEP ) effect, constant fraction of inspired oxygen, and good humidification
  • Noninvasive positive-pressure ventilation is a safe and effective means of improving gas exchange in patients with many types of acute respiratory failure . for example, adding noninvasive ventilation to standard therapy decreased the need for endotracheal intubation...For patients assigned to noninvasive ventilation, the ventilator was connected with conventional tubing to a clear, full-face mask with an inflatable soft-cushion seal and a disposable foam spacer to reduce dead space .After the mask had been secured, pressure support was increased to achieve an exhaled tidal volume of 8 to 10 ml per kilogram, a respiratory rate of fewer than 25 breaths per minute, the disappearance of accessory muscle activity (as evaluated by palpation of the sternocleidomastoid muscle), and patient comfort
  • The effects of high-flow nasal cannula (HFNC) on adult patients with acute respiratory failure (ARF) are controversial. The investigators aimed to further determine the effectiveness of HFNC in reducing the rate of endotracheal intubation in adult patients with ARF by comparison to noninvasive positive pressure ventilation (NIPPV)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patient suffer from acute respiratory failure and intubated for mechanical ventilation and then extubated for weaning
  • Age >18 years old

排除标准

  • In patients less than 18 years old
  • Any contradiction in using HFNC as trauma or surgery or obstruction of nasopharynx
  • Any contradiction in using NIPPV as facial trauma ..surgery ..deformity..or upper airway obstruction or upper gastrointestinal bleeding or high risk of aspiration

结局指标

主要结局

the need for re-intubation and weaning success which will be measured by arterial blood gas ( ABG )

时间窗: baseline

次要结局

  • Duration of using of HFNC or NIPPV(up to 30 days)
  • Length of hospital stay measured by days(up to 30 days)
  • Incidence of any possible complications associated with the use of HFNC and NIPPV(up to 30 days)
  • In - hospital mortality measured by number of died cases(up to 30 days)
  • Adverse events(up to 30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Osman Shehata Abdelkareem

resident doctor

Assiut University

相似试验